ロード中...
Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
INTRODUCTION: Dalbavancin is a bactericidal lipoglycopeptide active against gram-positives. Its use has been approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). METHODS: We conducted a narrative review of the literature on the safety profile of dalbavancin. The...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7997409/ https://ncbi.nlm.nih.gov/pubmed/33790563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S271445 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|